Are advanced manufacturing practices reshaping India’s role in international biosimilars market?
Will India’s life sciences future be defined by the strength of its collective ecosystem?
Is 2026 set to witness AI-driven disease surveillance and early diagnosis?
Is India’s clinical research landscape entering a new phase?